0001127602-18-001115.txt : 20180104 0001127602-18-001115.hdr.sgml : 20180104 20180104163214 ACCESSION NUMBER: 0001127602-18-001115 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180102 FILED AS OF DATE: 20180104 DATE AS OF CHANGE: 20180104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CAPELLO JEFFREY D CENTRAL INDEX KEY: 0001224108 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19311 FILM NUMBER: 18510536 MAIL ADDRESS: STREET 1: BOSTON SCIENTIFIC CORPORATION STREET 2: ONE BOSTON SCIENTIFIC PLACE CITY: NATICK STATE: MA ZIP: 01760 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOGEN INC. CENTRAL INDEX KEY: 0000875045 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 330112644 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 225 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 7814642000 MAIL ADDRESS: STREET 1: 225 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: BIOGEN IDEC INC. DATE OF NAME CHANGE: 20070427 FORMER COMPANY: FORMER CONFORMED NAME: BIOGEN IDEC INC DATE OF NAME CHANGE: 20031112 FORMER COMPANY: FORMER CONFORMED NAME: IDEC PHARMACEUTICALS CORP / DE DATE OF NAME CHANGE: 19970530 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2018-01-02 0000875045 BIOGEN INC. BIIB 0001224108 CAPELLO JEFFREY D BIOGEN INC. 225 BINNEY ST. CAMBRIDGE MA 02142 1 EVP & Chief Financial Officer Restricted Stock Unit 0 2018-01-02 4 A 0 8980 0 A 2021-01-02 Common Stock 8980 8980 D Performance Stock Unit 0 2018-01-02 4 A 0 5390 0 A Common Stock 5390 5390 D The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date]). The number of performance stock units ("PSUs") reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. The actual number of PSUs that will vest will be determined based upon achievement of three-year performance goals adopted by the Compensation and Management Development Committee of the Board of Directors (the "Committee") in the first quarter of 2018. All eligible PSUs will vest on the later of January 2, 2021 or the date of the Committee's determination of the degree to which the annual performance goals have been satisfied. /s/ Suzanne Murray, Attorney in Fact for Jeffrey Capello 2018-01-04